Glucocorticoid-dependent hippocampal transcriptome in male rats: Pathway-specific alterations with aging

Endocrinology

Volumn 154, Issue 8, 2013, Pages 2807-2820

  Chen, Kuey Chu ^a   Blalock, Eric M ^a   Curran Rauhut, Meredith A ^a   Kadish, Inga ^a   Blalock, Susan J ^a   Brewer, Lawrence ^a   Porter, Nada M ^a   Landfield, Philip W ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; TRANSCRIPTOME;

ADRENALECTOMY; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOWN REGULATION; DRUG PELLET; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLIA CELL; GLUCOSE METABOLISM; HIPPOCAMPAL CA1 REGION; IMMUNOREACTIVITY; INFLAMMATION; LEARNING; MALE; MICROARRAY ANALYSIS; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

ADRENALECTOMY; AGING; ANIMALS; BODY WEIGHT; CA1 REGION, HIPPOCAMPAL; CORTICOSTERONE; DRINKING; DRUG IMPLANTS; EATING; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOCORTICOIDS; IMMUNOHISTOCHEMISTRY; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED F344; RECEPTORS, GLUCOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84880655867     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1139     Document Type: Article

References (122)

1. Oakley RH, Cidlowski JA. Cellular processing of the glucocorticoid receptor gene and protein: New mechanisms for generating tissuespecific actions of glucocorticoids. J Biol Chem. 2011;286:3177-3184.
2. Chrousos GP, Kino T. Glucocorticoid signaling in the cell. Expanding clinical implications to complex human behavioral and somatic disorders. Ann NY Acad Sci. 2009;1179:153-166.
3. Barnes PJ. Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol. 2010;120:76-85.
4. Adcock IM, Ito K, Barnes PJ. Glucocorticoids: Effects on gene transcription. Proc Am Thorac Soc. 2004;1:247-254.
5. Tischner D, Reichardt HM. Glucocorticoids in the control of neuroinflammation. Mol Cell Endocrinol. 2007;275:62-70.
6. McEwenBS. Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol. 2008;583:174-185.
7. de Kloet ER, Karst H, Joëls M. Corticosteroid hormones in the central stress response: Quick-and-slow. Front Neuroendocrinol. 2008;29:268-272.
8. Joëls M, Sarabdjitsingh RA, Karst H. Unraveling the time domains of corticosteroid hormone influences on brain activity: Rapid, slow, and chronic modes. Pharmacol Rev. 2012;64:901-938.
9. McEwen BS. Physiology and neurobiology of stress and adaptation: Central role of the brain. Physiol Rev. 2007;87:873-904.
10. Kerr DS, Campbell LW, Applegate MD, Brodish A, Landfield PW. Chronic stress-induced acceleration of electrophysiologic and morphometric biomarkers of hippocampal aging. J Neurosci. 1991;11: 1316-1324.
11. Lupien SJ, Gaudreau S, Tchiteya BM, et al. Stress-induced declarative memory impairment in healthy elderly subjects: Relationship to cortisol reactivity. J Clin Endocrinol Metab. 1997;82:2070-2075.
12. Meaney MJ, Aitken DH, van Berkel C, Bhatnagar S, Sapolsky RM. Effect of neonatal handling on age-related impairments associated with the hippocampus. Science. 1988;239:766-768.
13. Swaab DF, Bao AM, Lucassen PJ. The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev. 2005; 4:141-194.
14. Dallman MF, Pecoraro NC, La Fleur SE, et al. Glucocorticoids, chronic stress, and obesity. Prog Brain Res. 2006;153:75-105.
15. Sapolsky RM, Krey LC, McEwen BS. Prolonged glucocorticoid exposure reduces hippocampal neuron number: Implications for aging. J Neurosci. 1985;5:1222-1227.
16. Landfield PW, Waymire JC, Lynch G. Hippocampal aging and adrenocorticoids: Quantitative correlations. Science. 1978;202:1098-1102.
17. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis. Endocr Rev. 1986;7:284-301.
18. McEwen BS. Re-examination of the glucocorticoid hypothesis of stress and aging. Prog Brain Res. 1992;93:365-381; discussion 382-363.
19. Porter NM, Landfield PW. Stress hormones and brain aging: Adding injury to insult? Nat Neurosci. 1998;1:3-4.
20. Landfield PW, Baskin RK, Pitler TA. Brain aging correlates: Retardation by hormonal-pharmacological treatments. Science. 1981; 214:581-584.
21. Reul JM, de Kloet ER.Tworeceptor systems for corticosterone in rat brain: Microdistribution and differential occupation. Endocrinology. 1985;117:2505-2511.
22. Cidlowski JA. Glucocorticoids and their actions in cells. Retina. 2009;29:SS23.
23. Dostert A, Heinzel T. Negative glucocorticoid receptor response elements and their role in glucocorticoid action. Curr Pharm Des. 2004;10:2807-2816.
24. Simons SS Jr. Glucocorticoid receptor cofactors as therapeutic targets. Curr Opin Pharmacol. 2010;10:613-619.
25. Lonard DM, Lanz RB, O'Malley BW. Nuclear receptor coregulators and human disease. Endocr Rev. 2007;28:575-587.
26. Rosenfeld MG, Lunyak VV, Glass CK. Sensors and signals: A coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 2006;20: 1405-1428.
27. Kelly MJ, Rønnekleiv OK. Control of CNS neuronal excitability by estrogens via membrane-initiated signaling. Mol Cell Endocrinol. 2009;308:17-25.
28. 2+ dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons. Brain Res. 2007;1172:48-59.
29. Simpkins JW, Richardson TE, Yi KD, Perez E, Covey DF. Neuroprotection with non-feminizing estrogen analogues: An overlooked possible therapeutic strategy. Horm Behav. 2013;63:278-283.
30. Samarasinghe RA, Witchell SF, DeFranco DB. Cooperativity and complementarity: Synergies in non-classical and classical glucocorticoid signaling. Cell Cycle. 2012;11:2819-2827.
31. Tasker JG, Herman JP. Mechanisms of rapid glucocorticoid feedback inhibition of the hypothalamic-pituitary-adrenal axis. Stress. 2011;14:398-406.
32. Dallman MF, Akana SF, Strack AM, et al. Chronic stress-induced effects of corticosterone on brain: Direct and indirect. Ann NY Acad Sci. 2004;1018:141-150.
33. Song IH, Buttgereit F. Non-genomic glucocorticoid effects to provide the basis for new drug developments. Mol Cell Endocrinol. 2006;246:142-146.
34. Walker DM, Juenger TE, Gore AC. Developmental profiles of neuroendocrine gene expression in the preoptic area of male rats. Endocrinology. 2009;150:2308-2316.
35. Nogueira EF, Bollag WB, Rainey WE. Angiotensin II regulation of adrenocortical gene transcription. Mol Cell Endocrinol. 2009;302: 230-236.
36. Dennis G Jr, Sherman BT, Hosack DA, et al. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4:P3.
37. Blalock EM, Chen KC, Sharrow K, et al. Gene microarrays in hippocampal aging: Statistical profiling identifies novel processes correlated with cognitive impairment. J Neurosci. 2003;23:3807-3819.
38. Draghici S, Khatri P, Bhavsar P, Shah A, Krawetz SA, Tainsky MA. Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate. Nucleic Acids Res. 2003;31:3775-3781.
39. Zhang B, Kirov S, Snoddy J. WebGestalt: An integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 2005;33:W741-748.
40. Miller JA, Oldham MC, Geschwind DH. A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging. J Neurosci. 2008;28:1410-1420.
41. Kajiyama Y, Iijima Y, Chiba S, et al. Prednisolone causes anxietyand depression-like behaviors and altered expression of apoptotic genes in mice hippocampus. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:159-165.
42. Liu Y, Yang N,ZuoP.cDNAmicroarray analysis of gene expression in the cerebral cortex and hippocampus of BALB/c mice subjected to chronic mild stress. Cell Mol Neurobiol. 2010;30:1035-1047.
43. Weaver IC, Meaney MJ, Szyf M. Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. Proc Natl Acad Sci USA. 2006;103:3480-3485.
44. Datson NA, Speksnijder N, Mayer JL, et al. The transcriptional response to chronic stress and glucocorticoid receptor blockade in the hippocampal dentate gyrus. Hippocampus. 2012;22:359-371.
45. Qin Y, Nair S, Karst H, Vreugdenhil E, Datson N, Joëls M. Gene expression changes in single dentate granule neurons after adrenalectomy of rats. Brain Res Mol Brain Res. 2003;111:17-23.
46. Datson NA, Morsink MC, Meijer OC, de Kloet ER. Central corticosteroid actions: Search for gene targets. Eur J Pharmacol. 2008; 583:272-289.
47. Morsink MC, Steenbergen PJ, Vos JB, et al. Acute activation of hippocampal glucocorticoid receptors results in different waves of gene expression throughout time. J Neuroendocrinol. 2006;18: 239-252.
48. Sohrabji F, Bake S. Age-related changes in neuroprotection: Is estrogen pro-inflammatory for the reproductive senescent brain? Endocrine. 2006;29:191-197.
49. Brinton RD. The healthy cell bias of estrogen action: Mitochondrial bioenergetics and neurological implications. Trends Neurosci. 2008;31:529-537.
50. Woolley CS, Weiland NG, McEwen BS, Schwartzkroin PA. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: Correlation with dendritic spine density. J Neurosci. 1997;17:1848-1859.
51. Yin W, Wu D, Noel ML, Gore AC. Gonadotropin-releasing hormone neuroterminals and their microenvironment in the median eminence: Effects of aging and estradiol treatment. Endocrinology. 2009;150:5498-5508.
52. Conrad CD. Chronic stress-induced hippocampal vulnerability: The glucocorticoid vulnerability hypothesis. Rev Neurosci. 2008;19: 395-411.
53. Wei Q, Hebda-Bauer EK, Pletsch A, et al. Overexpressing the glucocorticoid receptor in forebrain causes an aging-like neuroendocrine phenotype and mild cognitive dysfunction. J Neurosci. 2007; 27:8836-8844.
54. Seckl JR, Meaney MJ. Glucocorticoid programming. Ann NY Acad Sci. 2004;1032:63-84.
55. Kerr DS, Campbell LW, Hao SY, Landfield PW. Corticosteroid modulation of hippocampal potentials: Increased effect with aging. Science. 1989;245:1505-1509.
56. Issa AM, Rowe W, Gauthier S, Meaney MJ. Hypothalamic-pituitary-adrenal activity in aged, cognitively impaired and cognitively unimpaired rats. J Neurosci. 1990;10:3247-3254.
57. Lupien SJ, McEwen BS, Gunnar MR, Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci. 2009;10:434-445.
58. Green KN, Billings LM, Roozendaal B, McGaugh JL, LaFerla FM. Glucocorticoids increase amyloid-β and tau pathology in a mouse model of Alzheimer's disease. J Neurosci. 2006;26:9047-9056.
59. Sotiropoulos I, Catania C, Pinto LG, et al. Stress acts cumulatively to precipitate Alzheimer's disease-like tau pathology and cognitive deficits. J Neurosci. 2011;31:7840-7847.
60. Csernansky JG, Dong H, Fagan AM, et al. Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia.AmJ Psychiatry. 2006;163:2164-2169.
61. Carroll JC, Iba M, Bangasser DA, et al. Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy. J Neurosci. 2011; 31:14436-14449.
62. O'Callaghan JP, Brinton RE, McEwen BS. Glucocorticoids regulate the concentration of glial fibrillary acidic protein throughout the brain. Brain Res. 1989;494:159-161.
63. Nichols NR, Finch CE. Gene products of corticosteroid action in hippocampus. Ann NY Acad Sci. 1994;746:145-154; discussion 154-146.
64. McReynolds JR, Donowho K, Abdi A, McGaugh JL, Roozendaal B, McIntyre CK. Memory-enhancing corticosterone treatment increases amygdala norepinephrine and Arc protein expression in hippocampal synaptic fractions. Neurobiol LearnMem. 2010;93:312-321.
65. Beeri MS, Schmeidler J, Lesser GT, et al. Corticosteroids, but not NSAIDs, are associated with less Alzheimer neuropathology. Neurobiol Aging. 2012;33:1258-1264.
66. Landfield PW, Blalock EM, Chen KC, Porter NM. A new glucocorticoid hypothesis of brain aging: Implications for Alzheimer's disease. Curr Alzheimer Res. 2007;4:205-212.
67. Makino S, Schulkin J, Smith MA, Pacák K, Palkovits M, Gold PW. Regulation of corticotropin-releasing hormone receptor messenger ribonucleic acid in the rat brain and pituitary by glucocorticoids and stress. Endocrinology. 1995;136:4517-4525.
68. Bolstad BM, Collin F, Simpson KM, Irizarry RA, Speed TP. Experimental design and low-level analysis of microarray data. Int Rev Neurobiol. 2004;60:25-58.
69. Kadish I, Thibault O, Blalock EM, et al. Hippocampal and cognitive aging across the lifespan: A bioenergetic shift precedes and increased cholesterol trafficking parallels memory impairment. J Neurosci. 2009;29:1805-1816.
70. Buechel HM, Popovic J, Searcy JL, Porter NM, Thibault O, Blalock EM. Deep sleep and parietal cortex gene expression changes are related to cognitive deficits with age. PLoS One. 2011;6:e18387.
71. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med. 1990;9:811-818.
72. Rowe WB, Blalock EM, Chen KC, et al. Hippocampal expression analyses reveal selective association of immediate-early, neuroenergetic, and myelinogenic pathways with cognitive impairment in aged rats. J Neurosci. 2007;27:3098-3110.
73. Blalock EM, Buechel HM, Popovic J, Geddes JW, Landfield PW. Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease. J Chem Neuroanat. 2011;42:118-126.
74. Blalock EM, Grondin R, Chen KC, et al. Aging-related gene expression in hippocampus proper compared with dentate gyrus is selectively associated with metabolic syndrome variables in rhesus monkeys. J Neurosci. 2010;30:6058-6071.
75. Blalock EM, Chen KC, Stromberg AJ, et al. Harnessing the power of gene microarrays for the study of brain aging and Alzheimer's disease: Statistical reliability and functional correlation. Ageing Res Rev. 2005;4:481-512.
76. HuangdaW,Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44-57.
77. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25:25-29.
78. Huang da W, Sherman BT, Tan Q, et al. The DAVID Gene Functional Classification Tool: A novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 2007; 8:R183.
79. Sonntag WE, Goliszek AG, Brodish A, Eldridge JC. Diminished diurnal secretion of adrenocorticotropin (ACTH), but not corticosterone, in old male rats: Possible relation to increased adrenal sensitivity to ACTH in vivo. Endocrinology. 1987;120:2308-2315.
80. Dhabhar FS, McEwen BS, Spencer RL. Adaptation to prolonged or repeated stress-comparison between rat strains showing intrinsic differences in reactivity to acute stress. Neuroendocrinology. 1997; 65:360-368.
81. Kasckow J, Xiao C, Herman JP. Glial glucocorticoid receptors in aged Fisher 344 (F344) and F344/Brown Norway rats. Exp Gerontol. 2009;44:335-343.
82. Sapolsky RM. Do glucocorticoid concentrations rise with age in the rat? Neurobiol Aging. 1992;13:171-174.
83. De Kloet ER, Vreugdenhil E, Oitzl MS, Joëls M.Brain corticosteroid receptor balance in health and disease. Endocr Rev. 1998;19:269-301.
84. Landfield PW. Modulation of brain aging correlates by long-term alterations of adrenal steroids and neurally-active peptides. Prog Brain Res. 1987;72:279-300.
85. Dinapoli VA, Benkovic SA, Li X, et al. Age exaggerates proinflammatory cytokine signaling and truncates signal transducers and activators of transcription 3 signaling following ischemic stroke in the rat. Neuroscience. 2010;170:633-644.
86. O'Keefe GM, Nguyen VT, Benveniste EN. Regulation and function of class II major histocompatibility complex, CD40, and B7 expression in macrophages and microglia: Implications in neurological diseases. J Neurovirol. 2002;8:496-512.
87. Zamanian JL, Xu L, Foo LC, et al. Genomic analysis of reactive astrogliosis. J Neurosci. 2012;32:6391-6410.
88. Cintra A, Bhatnagar M, Chadi G, et al. Glial and neuronal glucocorticoid receptor immunoreactive cell populations in developing, adult, and aging brain. Ann NY Acad Sci. 1994;746:42-61; discussion 61-43.
89. Morsink MC, Van Gemert NG, Steenbergen PJ, Joëls M, De Kloet ER, Datson NA. Rapid glucocorticoid effects on the expression of hippocampal neurotransmission-related genes. Brain Res. 2007; 1150:14-20.
90. Kotti T, HeadDD,McKennaCE, RussellDW.Biphasic requirement for geranylgeraniol in hippocampal long-term potentiation. Proc Natl Acad Sci USA. 2008;105:11394-11399.
91. Guzowski JF, Setlow B, Wagner EK, McGaugh JL. Experience-dependent gene expression in the rat hippocampus after spatial learning: A comparison of the immediate-early genes Arc, c-fos, and zif268. J Neurosci. 2001;21:5089-5098.
92. Penner MR, Roth TL, Chawla MK, et al. Age-related changes in Arc transcription and DNA methylation within the hippocampus. Neurobiol Aging. 2011;32:2198-2210.
93. Mans RA, McMahon LL, Li L. Simvastatin-mediated enhancement of long-term potentiation is driven by farnesyl-pyrophosphate depletion and inhibition of farnesylation. Neuroscience. 2012;202: 1-9.
94. Vreugdenhil E, de Kloet ER, Schaaf M, Datson NA. Genetic dissection of corticosterone receptor function in the rat hippocampus. Eur Neuropsychopharmacol. 2001;11:423-430.
95. Hansson AC, Fuxe K. Time-course of immediate early gene expression in hippocampal subregions of adrenalectomized rats after acute corticosterone challenge. Brain Res. 2008;1215:1-10.
96. Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009;32:638-647.
97. Petanceska SS, DeRosa S, Sharma A, et al. Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol. J Mol Neurosci. 2003;20:395-406.
98. Magistretti PJ. Neuron-glia metabolic coupling and plasticity. J Exp Biol. 2006;209:2304-2311.
99. Rinholm JE, Hamilton NB, Kessaris N, Richardson WD, Bergersen LH, Attwell D. Regulation of oligodendrocyte development and myelination by glucose and lactate. J Neurosci. 2011;31:538-548.
100. Gross KL, Cidlowski JA. Tissue-specific glucocorticoid action: A family affair. Trends Endocrinol Metab. 2008;19:331-339.
101. Nixon M, Andrew R, Chapman KE. It takes two to tango: Dimerisation of glucocorticoid receptor and its anti-inflammatory functions. Steroids. 2013;78:59-68.
102. Chinenov Y, Gupte R, Dobrovolna J, et al. Role of transcriptional coregulator GRIP1 in the anti-inflammatory actions of glucocorticoids. Proc Natl Acad Sci USA. 2012;109:11776-11781.
103. Uhlenhaut NH, Barish GD, Yu RT, et al. Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes. Mol Cell. 2013;49:158-171.
104. Lewis-Tuffin LJ, Cidlowski JA. The physiology of human glucocorticoid receptor α (hGR?) and glucocorticoid resistance. Ann NY Acad Sci. 2006;1069:1-9.
105. Savory JG, Préfontaine GG, Lamprecht C, et al. Glucocorticoid receptor homodimers and glucocorticoid-mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces. Mol Cell Biol. 2001;21:781-793.
106. Chen Sy, Wang J, Yu Gq, Liu W, Pearce D. Androgen and glucocorticoid receptor heterodimer formation. A possible mechanism for mutual inhibition of transcriptional activity. J Biol Chem. 1997;272:14087-14092.
107. Farrell RJ, Kelleher D. Glucocorticoid resistance in inflammatory bowel disease. J Endocrinol. 2003;178:339-346.
108. Webster JI, Sternberg EM. Role of the hypothalamic-pituitaryadrenal axis, glucocorticoids and glucocorticoid receptors in toxic sequelae of exposure to bacterial and viral products. J Endocrinol. 2004;181:207-221.
109. Yao J, Hamilton RT, Cadenas E, Brinton RD. Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence. Biochim Biophys Acta. 2010;1800: 1121-1126.
110. Dilger RN, Johnson RW. Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system. J Leukoc Biol. 2008;84:932-939.
111. Gemma C, Bickford PC. Interleukin-1β and caspase-1: Players in the regulation of age-related cognitive dysfunction. Rev Neurosci. 2007;18:137-148.
112. McGeer PL, McGeer EG. Inflammation and the degenerative diseases of aging. Ann NY Acad Sci. 2004;1035:104-116.
113. Mrak RE, Griffin WS. Potential inflammatory biomarkers in Alzheimer's disease. J Alzheimers Dis. 2005;8:369-375.
114. Prolla TA, MattsonMP.Molecular mechanisms of brain aging and neurodegenerative disorders: Lessons from dietary restriction. Trends Neurosci. 2001;24:S21-S31.
115. Terry RD, DeTeresa R, Hansen LA. Neocortical cell counts in normal human adult aging. Ann Neurol. 1987;21:530-539.
116. Griffin WS. Neuroinflammatory cytokine signaling and Alzheimer's disease. N Engl J Med. 2013;368:770-771.
117. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci USA. 2009;106:14670-14675.
118. Wilkinson CW, Petrie EC, Murray SR, Colasurdo EA, Raskind MA, Peskind ER. Human glucocorticoid feedback inhibition is reduced in older individuals: Evening study. J Clin Endocrinol Metab. 2001;86:545-550.
119. Gottfried-Blackmore A, Sierra A, McEwen BS, Ge R, Bulloch K. Microglia express functional 11β-hydroxysteroid dehydrogenase type 1. Glia. 2010;58:1257-1266.
120. Yau JL, Seckl JR. Local amplification of glucocorticoids in the aging brain and impaired spatial memory. Front Aging Neurosci. 2012;4:24.
121. Meaney MJ, Szyf M. Maternal care as a model for experiencedependent chromatin plasticity? Trends Neurosci. 2005;28:456-463.
122. Wang Q, Joëls M, Swaab DF, Lucassen PJ. Hippocampal GR expression is increased in elderly depressed females. Neuropharmacology. 2012;62:527-533.